Suppr超能文献

利用临床试验数据估算潜在采用者行为干预措施的成本:试验研究者指南。

Using Clinical Trial Data to Estimate the Costs of Behavioral Interventions for Potential Adopters: A Guide for Trialists.

机构信息

Department of Medical Ethics and Health Policy, Perelman School of Medicine, and Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA, USA.

The Leonard Davis Institute of Health Economics (LDI), University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Med Decis Making. 2021 Jan;41(1):9-20. doi: 10.1177/0272989X20973160. Epub 2020 Nov 20.

Abstract

Behavioral interventions involving electronic devices, financial incentives, gamification, and specially trained staff to encourage healthy behaviors are becoming increasingly prevalent and important in health innovation and improvement efforts. Although considerations of cost are key to their wider adoption, cost information is lacking because the resources required cannot be costed using standard administrative billing data. Pragmatic clinical trials that test behavioral interventions are potentially the best and often only source of cost information but rarely incorporate costing studies. This article provides a guide for researchers to help them collect and analyze, during the trial and with little additional effort, the information needed to inform potential adopters of the costs of adopting a behavioral intervention. A key challenge in using trial data is the separation of implementation costs, the costs an adopter would incur, from research costs. Based on experience with 3 randomized clinical trials of behavioral interventions, this article explains how to frame the costing problem, including how to think about costs associated with the control group, and describes methods for collecting data on individual costs: specifications for costing a technology platform that supports the specialized functions required, how to set up a time log to collect data on the time staff spend on implementation, and issues in getting data on device, overhead, and financial incentive costs.

摘要

涉及电子设备、经济激励、游戏化和专门培训的员工以鼓励健康行为的行为干预措施在健康创新和改善工作中变得越来越普遍和重要。尽管成本考虑是广泛采用这些措施的关键,但由于无法使用标准行政计费数据对所需资源进行计价,因此缺乏成本信息。检验行为干预措施的实用临床试验可能是成本信息的最佳来源,而且通常也是唯一来源,但很少纳入成本研究。本文为研究人员提供了一个指南,帮助他们在试验期间并只需付出很少的额外努力收集和分析所需信息,为潜在采用者提供有关采用行为干预措施的成本信息。在使用试验数据时的一个关键挑战是将实施成本(采用者将承担的成本)与研究成本分开。基于对 3 项行为干预随机临床试验的经验,本文解释了如何构建成本核算问题,包括如何考虑与对照组相关的成本,以及描述了收集个人成本数据的方法:支持所需专门功能的技术平台的成本核算规范,如何设置时间记录以收集有关员工实施工作时间的数据,以及获取设备、间接费用和经济激励成本数据的问题。

相似文献

1
Using Clinical Trial Data to Estimate the Costs of Behavioral Interventions for Potential Adopters: A Guide for Trialists.
Med Decis Making. 2021 Jan;41(1):9-20. doi: 10.1177/0272989X20973160. Epub 2020 Nov 20.
2
Costing behavioral interventions: a practical guide to enhance translation.
Ann Behav Med. 2009 Apr;37(2):218-27. doi: 10.1007/s12160-009-9088-5. Epub 2009 Mar 17.
3
Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence.
J Acquir Immune Defic Syndr. 2013 May 1;63(1):e1-8. doi: 10.1097/QAI.0b013e318285d951.
7
The design and conduct of Keep It Off: An online randomized trial of financial incentives for weight-loss maintenance.
Clin Trials. 2017 Feb;14(1):29-36. doi: 10.1177/1740774516669679. Epub 2016 Sep 23.

引用本文的文献

1
Cost-Effectiveness of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease.
Circ Cardiovasc Qual Outcomes. 2025 Jul;18(7):e011839. doi: 10.1161/CIRCOUTCOMES.124.011839. Epub 2025 Jun 17.
3
Food Is Medicine: A Presidential Advisory From the American Heart Association.
Circulation. 2023 Oct 31;148(18):1417-1439. doi: 10.1161/CIR.0000000000001182. Epub 2023 Sep 28.
4
A randomized, controlled, prehabilitation intervention to maximize early recovery (PRIMER) in liver transplantation.
Liver Transpl. 2024 Jan 1;30(1):10-19. doi: 10.1097/LVT.0000000000000198. Epub 2023 Jun 29.
7
Effect of Financial Incentives for Process, Outcomes, or Both on Cholesterol Level Change: A Randomized Clinical Trial.
JAMA Netw Open. 2021 Oct 1;4(10):e2121908. doi: 10.1001/jamanetworkopen.2021.21908.
8
Cost-Effectiveness of Four Financial Incentive Programs for Smoking Cessation.
Ann Am Thorac Soc. 2021 Dec;18(12):1997-2006. doi: 10.1513/AnnalsATS.202012-1473OC.

本文引用的文献

1
Incentives for smoking cessation.
Cochrane Database Syst Rev. 2019 Jul 17;7(7):CD004307. doi: 10.1002/14651858.CD004307.pub6.
3
Rationale and Design of EMPOWER, a Pragmatic Randomized Trial of Automated Hovering in Patients With Congestive Heart Failure.
Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005126. doi: 10.1161/CIRCOUTCOMES.118.005126.
4
The Uncertain Effect of Financial Incentives to Improve Health Behaviors.
JAMA. 2019 Apr 16;321(15):1451-1452. doi: 10.1001/jama.2019.2560.
5
Interventions to improve adherence to lipid-lowering medication.
Cochrane Database Syst Rev. 2016 Dec 21;12(12):CD004371. doi: 10.1002/14651858.CD004371.pub4.
8
Real-time adherence monitoring for HIV antiretroviral therapy.
AIDS Behav. 2010 Dec;14(6):1340-6. doi: 10.1007/s10461-010-9799-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验